ADMA — ADMA Biologics Inc
In 2026 Q2, 6 of the 140 tracked hedge funds reported a position in ADMA Biologics Inc (ADMA), worth $35.17M combined. Over the quarter 3 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Duquesne | $23.30M | 0.54% | +80.1% |
| Renaissance | $5.46M | 0.00% | -48.3% |
| Ardsley | $5.02M | 0.55% | +41.2% |
| Quadrature | $683.64K | 0.00% | -60.1% |
| IMC | $369.05K | 0.00% | -29% |
| Caxton Associates | $334.20K | 0.00% | +164.3% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.